Briquilimab

3 trials

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

0 Recruiting

3 Completed trials

1 Sponsors

1 Countries

Phase II

Phase I/II

Phase II: 1 Phase I/II: 2

Indications tested

Urticaria chronic 2 Chronic spontaneous urticaria 1

Sponsors using this IMP

Jasper Therapeutics Inc. 3

All trials

3 total

A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants from Jasper-Sponsor… Ended

2024-517830-17-00 Phase II 1 country Jasper Therapeutics Inc.
Effect of briquilimab in patients with patches of itching skin because of chronic spontaneous urticaria (CSU) despite treatment with antihis… Ended

2023-505446-25-00 Phase I/II 1 country Jasper Therapeutics Inc.
A Phase 1b/2a, Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Pa… Ended

2023-507534-24-00 Phase I/II 1 country Jasper Therapeutics Inc.

Showing 1–3 of 3 trials

← All drugs A–Z